Bourbonnais, IL, United States of America

Scott M Kee

USPTO Granted Patents = 7 

 

 

Average Co-Inventor Count = 6.0

ph-index = 4

Forward Citations = 28(Granted Patents)


Company Filing History:


Years Active: 2010-2022

Loading Chart...
Loading Chart...
Loading Chart...
7 patents (USPTO):Explore Patents

Title: Scott M Kee: Innovator in Alpha-1-Antitrypsin Purification

Introduction

Scott M Kee is a notable inventor based in Bourbonnais, IL (US). He has made significant contributions to the field of biochemistry, particularly in the purification of alpha-1-antitrypsin (AAT). With a total of 7 patents to his name, Kee's work has the potential to impact pharmaceutical processes significantly.

Latest Patents

One of Kee's latest patents focuses on methods of treatment using alpha-1-antitrypsin compositions. This innovative method streamlines the purification of AAT from an AAT-containing protein mixture, such as Coh fraction IV precipitate. The process involves destabilizing contaminating proteins by cleaving disulfide bonds with a reducing reagent, such as dithiol, which does not affect AAT. The destabilized proteins are preferentially adsorbed on a solid protein-adsorbing material, eliminating the need for salt as a precipitant. The separation of the solid absorbent from the solution results in a purified AAT solution that is directly suitable for chromatographic purification, without extensive desalting as required in prior art processes. This method provides pharmaceutical-grade AAT in high yield on a commercial scale.

Career Highlights

Throughout his career, Scott M Kee has worked with prominent companies in the biopharmaceutical industry, including CSL Behring LLC and CSL Behring GmbH. His experience in these organizations has contributed to his expertise in the field of protein purification and treatment methods.

Collaborations

Kee has collaborated with notable professionals in his field, including Paul I Cook and James R Smith. These collaborations have likely enriched his research and development efforts, leading to innovative solutions in AAT purification.

Conclusion

Scott M Kee's contributions to the field of alpha-1-antitrypsin purification demonstrate his commitment to advancing biopharmaceutical processes. His innovative methods and collaborations highlight the importance of teamwork in achieving significant breakthroughs in science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…